ResearcherThe University of OsakaNo recent work listed
Kozo Noguchi
Matched on OpenAlex author ID A5108763329. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2015: 2 papers · 2016: none · 2017: none · 2018: 2 papers
Papers 4
- c-Met affects gemcitabine resistance during carcinogenesis in a mouse model of pancreatic cancer. Co-author DOI 10.3892/ol.2018.8793↗
- The mitochondrial one-carbon metabolic pathway is associated with patient survival in pancreatic cancer. Co-author DOI 10.3892/ol.2018.8795↗
- Susceptibility of pancreatic cancer stem cells to reprogramming. Co-author DOI 10.1111/cas.12734↗
- [Three Resected Cases of Metachronous Pancreatic Cancer Successfully Treated with Repeated Pancreatectomy]. Co-author PMID 26805359↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuichiro Doki · 4 shared papers, 2015–2018 · strength 0.22
- Paper c-Met affects gemcitabine resistance during carcinogenesis in a mouse model of pancreatic cancer. DOI 10.3892/ol.2018.8793↗
- Paper The mitochondrial one-carbon metabolic pathway is associated with patient survival in pancreatic cancer. DOI 10.3892/ol.2018.8795↗
- Paper Susceptibility of pancreatic cancer stem cells to reprogramming. DOI 10.1111/cas.12734↗
- Hidetoshi Eguchi · 4 shared papers, 2015–2018 · strength 0.22
- Paper c-Met affects gemcitabine resistance during carcinogenesis in a mouse model of pancreatic cancer. DOI 10.3892/ol.2018.8793↗
- Paper The mitochondrial one-carbon metabolic pathway is associated with patient survival in pancreatic cancer. DOI 10.3892/ol.2018.8795↗
- Paper Susceptibility of pancreatic cancer stem cells to reprogramming. DOI 10.1111/cas.12734↗
- Shigeru Marubashi · 3 shared papers, 2015–2018 · strength 0.16
- Paper c-Met affects gemcitabine resistance during carcinogenesis in a mouse model of pancreatic cancer. DOI 10.3892/ol.2018.8793↗
- Paper Susceptibility of pancreatic cancer stem cells to reprogramming. DOI 10.1111/cas.12734↗
- Paper [Three Resected Cases of Metachronous Pancreatic Cancer Successfully Treated with Repeated Pancreatectomy]. PMID 26805359↗
- Hiroaki Nagano · 3 shared papers, 2015–2018 · strength 0.16
- Paper c-Met affects gemcitabine resistance during carcinogenesis in a mouse model of pancreatic cancer. DOI 10.3892/ol.2018.8793↗
- Paper Susceptibility of pancreatic cancer stem cells to reprogramming. DOI 10.1111/cas.12734↗
- Paper [Three Resected Cases of Metachronous Pancreatic Cancer Successfully Treated with Repeated Pancreatectomy]. PMID 26805359↗
- Hideshi Ishii · 2 shared papers, 2018 · strength 0.13
- Tadafumi Asaoka · 2 shared papers, 2015–2018 · strength 0.11
- Daisaku Yamada · 2 shared papers, 2015–2018 · strength 0.11
- Hirofumi Akita · 1 shared paper, 2018 · strength 0.07
- Kunihito Gotoh · 1 shared paper, 2018 · strength 0.07
- Hideshi Ishii · 1 shared paper, 2015 · strength 0.05
- Masaki Mori · 1 shared paper, 2015 · strength 0.04
- Yoshito Tomimaru · 1 shared paper, 2015 · strength 0.04
- Hisataka Ogawa · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.